NO3140287T3 - - Google Patents

Info

Publication number
NO3140287T3
NO3140287T3 NO15725827A NO15725827A NO3140287T3 NO 3140287 T3 NO3140287 T3 NO 3140287T3 NO 15725827 A NO15725827 A NO 15725827A NO 15725827 A NO15725827 A NO 15725827A NO 3140287 T3 NO3140287 T3 NO 3140287T3
Authority
NO
Norway
Application number
NO15725827A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3140287T3 publication Critical patent/NO3140287T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO15725827A 2014-05-06 2015-05-06 NO3140287T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1454081A FR3020810B1 (fr) 2014-05-06 2014-05-06 Nouveau sel de l'ivabradine et son procede de preparation.
PCT/FR2015/051201 WO2015170053A1 (fr) 2014-05-06 2015-05-06 Nouveau sel de l'ivabradine et son procédé de préparation

Publications (1)

Publication Number Publication Date
NO3140287T3 true NO3140287T3 (hr) 2018-08-04

Family

ID=51518916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15725827A NO3140287T3 (hr) 2014-05-06 2015-05-06

Country Status (21)

Country Link
US (1) US9856221B2 (hr)
EP (1) EP3140287B1 (hr)
JP (1) JP2017514848A (hr)
CN (1) CN106458915B (hr)
AU (1) AU2015257518B2 (hr)
CA (1) CA2947475C (hr)
CY (1) CY1120402T1 (hr)
DK (1) DK3140287T3 (hr)
ES (1) ES2672927T3 (hr)
FR (1) FR3020810B1 (hr)
HR (1) HRP20180716T1 (hr)
HU (1) HUE037755T2 (hr)
LT (1) LT3140287T (hr)
MA (1) MA39756B1 (hr)
ME (1) ME03062B (hr)
NO (1) NO3140287T3 (hr)
PL (1) PL3140287T3 (hr)
PT (1) PT3140287T (hr)
RS (1) RS57147B1 (hr)
SI (1) SI3140287T1 (hr)
WO (1) WO2015170053A1 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI784370B (zh) 2017-01-31 2022-11-21 美商基利科學股份有限公司 替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
PT1901749T (pt) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Fluoroquinolonas aerossolizadas e suas utilizações
WO2007064845A1 (en) * 2005-11-29 2007-06-07 Pr Pharmaceuticals, Inc. Sustained release butorphanol drug delivery compositions for analgesia
US8653106B2 (en) * 2010-07-30 2014-02-18 Pisgah Laboratories, Inc. Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
US20080293695A1 (en) * 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5801295B2 (ja) * 2009-06-24 2015-10-28 メルク・シャープ・エンド・ドーム・ベー・フェー アセナピンを含有する注射可能な配合物およびそれを用いた処置方法
WO2011104723A2 (en) * 2010-02-23 2011-09-01 Ind-Swift Laboratories Limited Acid addition salts of ivabradine and preparation thereof
PT2579860E (pt) * 2010-06-14 2014-05-30 Ratiopharm Gmbh Composição farmacêutica que contém ivabradina com libertação modificada
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
US9040695B2 (en) * 2011-04-26 2015-05-26 Torrent Pharmaceuticals Limited Acid addition salts of risperidone and pharmaceutical compositions thereof
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects

Also Published As

Publication number Publication date
EP3140287A1 (fr) 2017-03-15
SI3140287T1 (en) 2018-05-31
EP3140287B1 (fr) 2018-03-07
RS57147B1 (sr) 2018-07-31
ME03062B (me) 2019-01-20
HUE037755T2 (hu) 2018-09-28
WO2015170053A1 (fr) 2015-11-12
CA2947475C (fr) 2018-07-10
JP2017514848A (ja) 2017-06-08
CA2947475A1 (fr) 2015-11-12
AU2015257518B2 (en) 2018-12-13
MA39756B1 (fr) 2018-05-31
PT3140287T (pt) 2018-03-22
FR3020810B1 (fr) 2016-05-06
MA39756A (fr) 2018-03-07
HRP20180716T1 (hr) 2018-06-15
FR3020810A1 (fr) 2015-11-13
US9856221B2 (en) 2018-01-02
PL3140287T3 (pl) 2018-07-31
US20170050932A1 (en) 2017-02-23
CN106458915A (zh) 2017-02-22
DK3140287T3 (en) 2018-06-14
ES2672927T3 (es) 2018-06-18
CY1120402T1 (el) 2019-07-10
AU2015257518A1 (en) 2016-11-03
CN106458915B (zh) 2019-05-07
LT3140287T (lt) 2018-04-10

Similar Documents

Publication Publication Date Title
BR112016022558A2 (hr)
BR112016020776A2 (hr)
BR112016021730A2 (hr)
BR112016020566A2 (hr)
BR112016023047A2 (hr)
BR112016022474A2 (hr)
BR112016027265A2 (hr)
BR112016021661A2 (hr)
BR112016022165A2 (hr)
BR112016027071A2 (hr)
RU2017122460A3 (hr)
BR112016021583A2 (hr)
BR112016026979A2 (hr)
BR112016019462A2 (hr)
BR112016021941A2 (hr)
BR112016027088A2 (hr)
BR112016025669A2 (hr)
BR112016021784A2 (hr)
BR112016021098A2 (hr)
BR112016020595A2 (hr)
BR112016026642A2 (hr)
BR112016019183A2 (hr)
BR112016021347A2 (hr)
BR112016026105A2 (hr)
BR112016026303A2 (hr)